Pregnancy · Research · Informed Choice

What the acetaminophen research says for pregnancy, and what it doesn’t

If you are pregnant right now, you have probably been scared about Tylenol.

Maybe a headline did it. Maybe a relative sent you a video. Maybe you were standing in a pharmacy aisle with a pounding head and a low-grade fever, holding the one pain reliever considered safest in pregnancy, suddenly afraid to take it. That fear did not come from nowhere, and it did not come from good counseling. It came from a very loud year.

I want to walk you through what the research actually shows, and just as importantly, what it does not. Because you deserve to make this decision informed, not terrified.

The autism claims, and what the evidence says

In the fall of 2025, senior U.S. officials publicly linked acetaminophen use in pregnancy to autism, and the president advised pregnant women not to take Tylenol. It spread fast. It also went well past what the science supports, and doctors said so almost immediately.

Here is where the evidence landed. In January 2026, a large review published in The Lancet’s obstetrics and women’s health journal pulled together around sixty studies, some with millions of participants, and found no causal link between acetaminophen taken as directed and autism, ADHD, or intellectual disability. A key reason earlier studies looked alarming is a research problem called confounding. Families who use more acetaminophen often differ in other ways, including genetics, and those differences can create a false signal.

The cleanest way to test that is a sibling comparison, looking at brothers and sisters where one was exposed in the womb and one was not. When researchers do that, the association tends to disappear. A Swedish study of roughly 2.8 million births using that method found no link. Studies from Denmark and Japan through 2026 reached the same place. This is why major bodies including the World Health Organization and the American College of Obstetricians and Gynecologists have continued to say that short-term, guideline-appropriate acetaminophen use is reasonable in pregnancy.

The risk of being too scared to treat

Here is the part the headlines skipped, and it is the part that worries me most as someone who cared for high-risk pregnancies for years.

A high fever left untreated in pregnancy is not neutral. It carries real, documented risks, including miscarriage, birth defects, and preterm birth. Significant unmanaged pain has costs too. When we frighten women away from the one option generally considered safest, we do not make them safer. We just leave them white-knuckling a 103 degree fever because they are more afraid of the medicine than the fever. That is a real harm, and it lands hardest on the women who already get the least support.

So no, you should not power through a raging fever out of fear. That is not caution. That is a different risk wearing caution’s clothing.

The quieter question nobody is shouting about

Now, in the spirit of telling you everything and not just the reassuring half, there is a separate line of research that deserves honesty.

While the autism conversation dominated the news, a Danish study called COPANA looked at something different: the reproductive development of infant girls exposed to acetaminophen in the womb. Following girls whose mothers used it within recommended limits, researchers found associations with altered markers of ovarian development and smaller uterine and ovarian size in infancy. It lines up with years of animal studies showing reduced ovarian follicle reserve after fetal exposure.

I am not telling you that to scare you back the other way. Read this carefully, because the nuance is the whole point. COPANA is observational, from a single center, and relatively small, a few hundred girls. It measures markers in infancy, not proven fertility outcomes down the road, and it cannot by itself prove cause and effect. Major obstetric guidance has not changed based on it. It is an early, serious question worth watching, not a settled fact and not a reason to panic.

Notice what that means. The loud claim, autism, is the one the best evidence does not support. The quiet one, reproductive development, is more open and got almost no airtime. That gap tells you a lot about how women’s health gets covered.

What informed actually looks like

Put the two halves together and you get something that is neither fear nor false comfort.

Acetaminophen remains the first-line option for fever and pain in pregnancy for good reasons. The sensible approach the evidence supports is the lowest effective dose for the shortest time you actually need it, rather than habitual daily use, and always in conversation with your own provider about your situation. Treat a real fever. Do not reach for it reflexively for every minor ache if you have other safe comfort measures. Ask questions, and expect real answers instead of headlines.

That middle ground is not exciting. It will never trend. But it is the truth, and you were owed the truth long before you were owed a scare.

At Nesting in You, the second word of how we work is Educate, and this is what that means. Not telling you what to do. Handing you the actual picture, both sides of it, so the choice stays yours.

Nesting in You provides maternal wellness education and coaching. We do not diagnose, treat, or prescribe. This article is for information, not medical advice. Always talk with your own provider about medication in pregnancy. Sources referenced: The Lancet Obstetrics, Gynecology & Women’s Health meta-analysis (2026); Swedish, Danish, and Japanese cohort and sibling-comparison studies (2024 to 2026); the COPANA study on prenatal paracetamol and ovarian development (2026); guidance from ACOG and the WHO.